Beneficiary Inducements

Similar documents
Part 1: Patient Inducements. What can and cannot be offered? Beneficiary Inducements and Financial Relationships with Patients. Jill Wright.

and Financial Relationships with Patients HCCA Boston Regional Conference September 8, 2017

CBI PAP LEGAL UPDATE MEDICARE & MEDICAID A REVIEW OF COMPLIANCE WITH GOVERNMENT PROGRAMS. September 26, Sarah difrancesca Partner Cooley LLP

OIG Changes to Anti-Kickback Safe Harbor Provisions and the CMP Beneficiary Inducement Prohibition

HEALTH CARE FRAUD. EXPERT ANALYSIS HHS OIG Adopts New Anti-Kickback Safe Harbor and Civil Monetary Penalty Exceptions

Patient Access Programs: A Legal Perspective

Federal Administrative Sanctions

Stark Self-Referral Disclosure Protocol

Managing Financial Interests: The Anti Kickback Statute (AKS)

Gifts to Referral Sources. Kim C. Stanger (11-17)

Supplemental Special Advisory Bulletin: Independent Charity. Patients who cannot afford their cost-sharing obligations

Health Care Compliance Association

SIGNIFICANT PROPOSED CHANGES TO THE ANTI- KICKBACK STATUTE AND THE CIVIL MONETARY PENALTIES LAW

Stark and the Anti Kickback Statute. Regulating Referral Relationship. February 27-28, HCCA Board Audit Committee Compliance Conference.

1 of 9 5/27/2011 2:20 PM

CPT is a registered trademark of the American Medical Association.

AGENCY: Office of Inspector General (OIG) HHS. to the anti-kickback statute and the civil monetary penalty

Industry Funding of Continuing Medical Education

Federal Fraud and Abuse Enforcement in the ASC Space

7/25/2018. Government Enforcement in the Clinical Laboratory Space. The Statutes & Regulations. The Stark Law. The Stark Law.

Compliance Program. Health First Health Plans Medicare Parts C & D Training

The Anesthesia Company Model: Frequently Asked Questions

Improving Integrity in Nursing Centers

Telemedicine Fraud and Abuse Under the Microscope

Hospital Incentive Payments to Physicians for Quality and Cost Savings

Overview of Pay For Performance

Special Advisory Bulletin

Repay Overpayments (18 USC 1347; 42 CFR et seq.)

H e a l t h C a r e Compliance Adviser

REGULATORY ISSUES IMPACTING SUPPLY CHAIN

Association of Corporate Counsel January 2012 Teleconference CMS Finally Issues Proposed Sunshine Act Regulations

Manufacturer Patient Support Initiatives: Current Practices and Recent Challenges. Andrew Ruskin Morgan Lewis

Bogies: Federal Anti- Kickback Law & EMS Contracting - Emerging Issues Pamela L. Johnston Foley & Lardner LLP Partner, Los Angeles.

Top 10 Issues in APM Contract Negotiations

2014 Lathrop & Gage LLP Lathrop & Gage LLP Lathrop & Gage LLP

STRIDE sm (HMO) MEDICARE ADVANTAGE Fraud, Waste and Abuse

The Anti-Kickback Statute. May 3, 2013 Tennessee Hospice Organization Compliance Forum

COMPLIANCE WITH PATIENT ASSISTANCE PROGRAMS AND CO-PAY CARDS. Judd Katz JD MHA November 2016

Next Webinar: Third-Party Billing Agreements Does Your Contract Protect Your Interests? May 10, 2016 at Noon ET (11am CT, 9am PT)

HELAINE GREGORY, ESQ.

Investigator Compensation: Motivation vs. Regulatory Compliance

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training. Developed by the Centers for Medicare & Medicaid Services

FINANCIAL DISCLOSURES AND CONFLICTS OF INTEREST IN CLINICAL RESEARCH

This course is designed to provide Part B providers with an overview of the Medicare Fraud and Abuse program including:

Fraud and Abuse Laws. Kim C. Stanger. Compliance Bootcamp (5/18)

IDN Goals (cont d) Integrated Delivery Networks and What They Mean for Compliance. Integrated Delivery Network (IDN) Goals

Lifetime Limits Effective September 23, 2010, payors are prohibited from placing lifetime dollar limits on medical claims.

Stark Self-Disclosure. Thomas S. Crane 1/ Mintz Levin Cohn Ferris Glovsky and Popeo, PC

You Can't Do What? Legal Guidance for Marketing

Patient Assistance Programs

AHLA. F. Anti-Kickback Primer. David E. Matyas Epstein Becker & Green PC Washington, DC

Florida Health Law Traps -

Goals for Today s Presentation

Fraud and Abuse Compliance for the Health IT Industry

Beware Excluded Individuals and Entities

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training

OFFICE OF INSPECTOR GENERAL WORK PLAN FISCAL YEAR 2006 MEDICARE HOSPITALS

Anti-Kickback Statute Jess Smith

Exploring the Interaction between Medicare Part B and Medicare Part D

PHASE II OF THE FINAL STARK REGULATIONS: WHAT DO THEY MEAN FOR HEALTHCARE PROVIDERS

Ensuring Compliance with the Law - Properly Structuring Innovative Marketing and Creative Joint Ventures. Top 5 Things to Know for CE:

Ensuring Compliance with the Law - Properly Structuring Innovative Marketing and Creative Joint Ventures. Clay Stribling, Esq.

Sender's Direct Phone (202) Sender's Direct Facsimile (202) MEMORANDUM

Anti-Kickback Statute and False Claims Act Enforcement

Current Issues in Patient and Product Support. October 20, 2016

PO Box 350 Willimantic, Connecticut (860) (800) Connecticut Ave, NW Suite 709 Washington, DC (202)

What is the HHS OIG?

Finding the Rx for Your Patient Assistance Program CBI Manufacturer Workgroup Presented by Ross Margulies, Esq. Foley Hoag LLP March 17, 2017

Reed Smith MEMORANDUM HEALTH CARE CLIENTS. DATE: July 26, RE: OIG Advisory Opinion 01-8 I. INTRODUCTION

Introduction to the Centers for Medicare & Medicaid Services (CMS) Payment Process

Fraud and Abuse Laws. Overview. Kim C. Stanger Compliance Bootcamp

CMS 60-Day Rule: Reporting and Refunding Overpayments for Providers and Suppliers One Year Later

RESEARCH ENFORCEMENT Grant Fraud, Research Billing Irregularities and Other Scary Research Enforcement Issues

DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All NEW YORK WORKFORCE MEMBERS

Fraud and Abuse Laws: Understanding, Applying and Avoiding Liability

Health Care Pricing: Establishing Fees, Discounts, Charging Interest, Out-of- Network Arrangements and Other Issues

HAR However, the PPACA remains the law and we have a duty to enforce and uphold the law.

Recent and Emerging Issues Related to Clinical Laboratory Testing and How to Avoid Them. Compliance

PURCHASING INTERNET LEADS: SURE, IT CAN BE DONE, BUT BE VERY CAREFUL. Denise Leard, Esq Brown & Fortunato, P.C.

Corporate Compliance Program. Intended Audience: All SEH Associates 2016 Content Expert: Lisa Frey -

Developed by the Centers for Medicare & Medicaid Services Issued: February, 2013

REQUIREMENTS FOR THE EARLY RETIREE REINSURANCE PROGRAM

FRAUD AND ABUSE LAW IMPLICATED BY COMPENSATION ARRANGEMENTS. Lee Rosebush, PharmD, RPh, MBA, JD

The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer s Perspective

AND THE NEED TO UNDERTAKE

Completing the Journey through the World of Compliance. Session # COM6, March 5, 2018 Gabriel L. Imperato, Managing Partner Broad and Cassel

Self-Disclosure: Why, When, Where and How

Self-Disclosures: Report, Repayment & the Options HCCA s 22nd Annual Compliance Institute

Disclaimer. The materials and views expressed in this presentation are the views of the presenters and not necessarily the views of Northwell Health

Medicare Parts C & D General Compliance Training

Contracting With Research Sites And Investigators: A Fraud And Abuse Primer

Developed by the Centers for Medicare & Medicaid Services

hfma September 21, 2018

Government Documents Regarding Civil Fraud and White-Collar Offenses

Medicare Parts C & D Fraud, Waste, and Abuse Training

Contracting with Specialty Pharmacies and Hubs 17 th Annual Pharma and Medical Device Compliance Congress. October 20, 2016

August 11, Submitted electronically via Regulations.gov

Medicare Advantage (Part C) Review

Legal Issues: Fraud and Abuse Navigating Stark and Kickback. Reece Hirsch, Esq. Jordana Schwartz, Esq. HIT Summit West March 7, 2005

A DISCUSSION WITH THE OIG

Transcription:

1 Beneficiary Inducements Heidi A. Sorensen HCCA South Central Regional Annual Conference November 12, 2010 Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative of clients 321 N. Clark Street, Suite 2800, Chicago, IL 60654 312.832.4500

Overview Understanding Illegal Inducements PPACA Changes Sources of Guidance 1991 Special Fraud Alert 2002 Special Advisory Bulletin Compliance Program Guidance Advisory Opinions Risk Areas

What is an illegal inducement? Offering or transferring remuneration to a beneficiary of Medicare or a State health care program (including Medicaid) that is likely to influence the beneficiary to order or receive from a particular provider, practitioner, or supplier any item or service covered under Medicare or a State health care program. 42 U.S.C. Sec. 1320a-7a(a)(5). Requires intent (knew or should have known, which equals actual knowledge, deliberate ignorance or reckless disregard)

What is remuneration? Transfers of items or services for free or for other than fair market value. Waiver of coinsurance and deductible amounts (or any part thereof), unless they meet certain conditions: Not offered as part of an advertisement or solicitation Waivers are not routine Good faith determination of beneficiary financial need Failed to collect after reasonable efforts.

What else isn t an inducement? Inexpensive, non-cash gifts of less than $10 each and no more than $50 in the aggregate on an annual, per patient basis (no inflation adjustments to date). Incentives to individuals to promote the delivery of preventive care services Cannot be tied to the provision of other Medicare or State health care program services No cash or instruments convertible to cash No disproportionally large incentives

What else isn t an inducement? Properly disclosed copayment differentials in health plans Practices permitted under the federal Antikickback Statute Waivers of hospital outpatient co-payments in excess of minimum co-payment amounts

How did PPACA change inducements? New additional remuneration exceptions: Remuneration that promotes access to care and poses low risk of harm to patients and the Federal health care programs. Certain transfers of coupons, rebates, or retailer awards. Unadvertised transfers of items or services, connected to medical care, based on financial need.

How did PPACA change inducements? (cont.) Final additional remuneration exception to be implemented no earlier than Jan. 1, 2011: Waiver by Prescription Drug Plan sponsor or Medicare Advantage Plan organization of any copayment for the first fill of a covered Part D generic drug for individuals enrolled in its PDP or MA-PDP.

What are the penalties? Civil monetary penalty of not more than $10,000 for each item or service ( wrongful act per regulations) Assessment of not more than 3 times the amount claimed for each item or service; OR 3 times the amount of the remuneration (if also AKS violation) Exclusion Injunctive Relief Agency liability May also be violation of Antikickback Statute (FCA liability, CMPL liability, criminal liability).

How does the government enforce prohibitions? Document and testimonial subpoena authority CMPL: Administrative proceeding before an administrative law judge with appeal to Departmental Appeals Board and then federal Circuit Court. AKS: Criminal or civil proceeding in federal District Court. Settlements (or plea agreements) can be with either DOJ, OIG, or both.

Why does the government care? Quality concerns - offset cost of illegal inducement by reducing quality Cost Concerns - offset cost of illegal inducement by providing medically unnecessary services Favors larger providers who can better afford inducements and disadvantages smaller providers. Sign of other compliance problems

1991 Special Fraud Alert Addressed routine waivers of Part B copayments and deductibles. Concerned about false claims, AKS violations, excessive utilization. Focused on charge-based (as opposed to costbased) providers because routine waivers misstate actual charges. Beneficiaries who have cost-sharing obligations are better health care consumers Introduced hardship exception

1991 Special Fraud Alert (cont.) Cautioned against advertising: Medicare Accepted As Payment in Full Insurance Accepted As Payment in Full No Out-of-Pocket Expenses Routine use of financial hardship waivers without good faith attempt to assess need or reasonable collection efforts Sham insurance programs to cover copayments and deductibles

2002 Special Advisory Bulletin Announced the $10/$50 limits for nominal value Expect to limit favorable advisory opinions to situations very close to existing exceptions Provider funding of independent patient advocacy group or other organization to help beneficiaries okay so long as independent determination of need and receipt of remuneration not dependent on use of a particular provider Concern about indirect or word of mouth promotion or passive marketing

2002 Special Advisory Bulletin No special exception for beneficiaries with chronic medical conditions. Expressed concern about escalating inducement At time, was considering new exceptions for: Complimentary local transportation Government-sponsored clinical trials Purchase of Medicare supplemental insurance by dialysis providers for persons with ESRD.

Compliance Program Guidance Examples include -- Hospital CPG: Addresses free transportation, cost-sharing waivers, discounts to uninsured patients (which are often confused with beneficiary inducements), and preventive care services. DMEPOS CPG: Addresses gifts to beneficiaries and marketing practices that potentially implicate CMPL.

Advisory Opinions Advisory Opinion 10-18 (favorable - free onenight post-surgical accommodations for pediatric tonsillectomy patients) Advisory Opinion 09-11 (favorable free blood pressure screenings to walk-in visitors at hospital) Advisory Opinion 09-01 (favorable complimentary local transportation program for friends and family of SNF residents)

Advisory Opinions (cont.) Advisory Opinion 08-03 (favorable prompt pay discounts) Advisory Opinion 06-01 (unfavorable free preoperative home safety assessments) Advisory Opinion 01-14 (favorable waiver of copayment related to certain cancer screening services)

Risk Areas Transportation Health Fairs/Baby Showers/Free screening Patient Discounts Patient gifts and marketing practices Rule: Use common sense and assess how likely a proposed inducement will be to influence beneficiaries.

Resources Beneficiary Inducement Civil Monetary Penalty, 42 U.S.C. Sec. 1320a-7a(a). Antikickback Statute, 42 U.S.C. Sec. 1320a-7b(b). 42 CFR Part 1003 Special Fraud Alert: Routine Waiver of Copayments or Deductibles under Medicare Part B (May 1991). Special Advisory Bulletin, Offering Gifts and Other Inducements to Beneficiaries (Aug. 2002). OIG Advisory Opinions.

Questions? Heidi A. Sorensen, Esq. Foley & Lardner, LLP 3000 K Street, N.W., Suite 600 Washington, DC 20007 202-672-5596 hsorensen@foley.com www.foley.com